Frontiers in medicine · 2025
Ultrasound-guided fascia iliaca compartment block versus intravenous analgesia in geriatric hip fractures: a systematic review and meta-analysis of randomized trials demonstrating superior pain control.
СтатьяСистематический обзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Liu Chang, Han Shunyu, Wei Ai, Yang Lina, Yang Mengchang
Аннотация
BACKGROUND: Severe pain in elderly hip fracture patients exacerbates perioperative risks. This meta-analysis compares ultrasound-guided fascia iliaca compartment block (UG-FICB) with intravenous analgesia for pain management.
METHODS: A comprehensive search of randomized controlled trials (RCTs) published through February 2025 was conducted across major databases, including English-language databases and Chinese databases. Outcomes analyzed via RevMan 5.3 using random/fixed-effect models. Primary outcomes encompassed Visual Analog Scale (VAS) scores, analgesic consumption, patient satisfaction, main adverse reactions, and gastrointestinal adverse events. Secondary outcomes included intraoperative blood loss, operative time, length of stay, and respiratory adverse events.
RESULTS: A total 26 RCTs (n = 2,347), UG-FICB significantly not only reduced Visual Analog Scale (VAS) scores at all timepoints: 0.5 h (p = 0.02), 2 h (p = 0.001), 4 h (p = 0.002), 6 h (p < 0.00001), 12 h (p = 0.0002), 24 h (p < 0.00001), and 48 h postoperatively (p = 0.003), but also reduced postoperative analgesic consumption (OR = 5.27, p < 0.00001). Patients receiving UG-FICB exhibited fewer drug-related adverse events, including dizziness (OR = 2.34), hypersomnia (OR = 3.58), and gastrointestinal complications (nausea OR = 2.57; constipation OR = 4.82; p < 0.05). UG-FICB also shortened length of stay (MD = 1.88 days, p < 0.00001) and enhanced satisfaction (OR = 0.26, p = 0.0002).
CONCLUSION: Compared to intravenous analgesia, UG-FICB provides superior, sustained pain relief with fewer opioid-related complications and higher patient satisfaction. UG-FICB's safety and efficacy advantages strongly support its adoption as first-line therapy in geriatric hip fractures protocols.
METHODS: A comprehensive search of randomized controlled trials (RCTs) published through February 2025 was conducted across major databases, including English-language databases and Chinese databases. Outcomes analyzed via RevMan 5.3 using random/fixed-effect models. Primary outcomes encompassed Visual Analog Scale (VAS) scores, analgesic consumption, patient satisfaction, main adverse reactions, and gastrointestinal adverse events. Secondary outcomes included intraoperative blood loss, operative time, length of stay, and respiratory adverse events.
RESULTS: A total 26 RCTs (n = 2,347), UG-FICB significantly not only reduced Visual Analog Scale (VAS) scores at all timepoints: 0.5 h (p = 0.02), 2 h (p = 0.001), 4 h (p = 0.002), 6 h (p < 0.00001), 12 h (p = 0.0002), 24 h (p < 0.00001), and 48 h postoperatively (p = 0.003), but also reduced postoperative analgesic consumption (OR = 5.27, p < 0.00001). Patients receiving UG-FICB exhibited fewer drug-related adverse events, including dizziness (OR = 2.34), hypersomnia (OR = 3.58), and gastrointestinal complications (nausea OR = 2.57; constipation OR = 4.82; p < 0.05). UG-FICB also shortened length of stay (MD = 1.88 days, p < 0.00001) and enhanced satisfaction (OR = 0.26, p = 0.0002).
CONCLUSION: Compared to intravenous analgesia, UG-FICB provides superior, sustained pain relief with fewer opioid-related complications and higher patient satisfaction. UG-FICB's safety and efficacy advantages strongly support its adoption as first-line therapy in geriatric hip fractures protocols.